BPC Instruments (BPCINS) Q2 2025 earnings summary

Executive summary

• Achieved 20% year-over-year revenue growth in Q2 2025, with strong performance in EMEA and healthy demand in Asia-Pacific, Scandinavia, and North America.

• Secured the largest order in company history post-quarter, supporting future growth in the biodegradability platform.

• Continued investment in technology, team development, and digital workflows to meet rising demand and maintain quality.

Financial highlights

• Q2 2025 net sales: KSEK 16,879 (up from 14,073 in Q2 2024); EBIT: KSEK 2,436 (down from 3,240); net profit: KSEK 2,003 (down from 2,537); EPS: SEK 0.18 (down from 0.24).

• H1 2025 net sales: KSEK 30,019 (up from 29,217 in H1 2024); EBIT: KSEK 3,427 (down from 9,573); net profit: KSEK 2,342 (down from 8,199); EPS: SEK 0.21 (down from 0.78).

• Total cash and equivalents (including long-term investments) at period end: KSEK 59,680 (up from 25,410).

Outlook and guidance

• Management expects continued growth, supported by a diversified pipeline and recent large orders.

• Investments in R&D, quality assurance, and digital infrastructure to support scalable growth.

• Positive outlook for the biogas and biodegradability markets, with ongoing recovery in China and strong demand in EMEA.